OSAKA -- Japanese drugmaker Shionogi's COVID-19 vaccine candidate was found to be as effective as Pfizer shots as a booster in a late-stage clinical trial, the company announced Friday.
COVID vaccines
Japan's Shionogi booster delivers similar results to Pfizer: study
Deliveries of COVID vaccine to start as early as May after trial success
